Today we're joined by Dr. Joshua Britton, founder and CEO of Debut Biotech, a cell-free biomanufacturing company. Josh gives us a crash course on synthetic biology and biomanufacturing, walking us through the various methods and promise of this industry that may very well shift industrial production away from fossil fuels. We also get into some of the founding story of Debut, including how Cantos' investment in Debut came to be...hint: it had to do with a cold message.
Shownotes:
June 13, 2023
Today we're joined by Mike Horowitz and Scott Patterson, co-founders of Modulo. Modulo is designing therapeutics to reprogram your neuroimmune system by focusing on...
00:47:56
March 16, 2022
We talk to Prellis Biologics founder Melanie Matheu about bioprinting organs with Prellis' holographic laser technology, using bioprinted lymph node organoids for antibody discovery,...
00:38:29
February 09, 2022
Cantos analysts Amee and Andrew dive into their top predictions for what deep tech might see in 2022. Shownotes: Our 2022 predictions blog post...
00:29:53
